SEC Form 4 · accession 0000899243-18-005870
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | M | 5,000 | $1.5068 | A | 79,390 | D | |
| Common Stock | Feb 26, 2018 | S | 5,000 | $60.00 | D | 74,390 | D | |
| Common Stock | holding | — | — | — | 85,973 | I | By Reporting Person's Trust 2 | |
| Common Stock | holding | — | — | — | 500,000 | I | By Reporting Person's Trust 3 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 1 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 2 | |
| Common Stock | holding | — | — | — | 12,200 | I | By Trust 3 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.5068 | Feb 26, 2018 | M | 5,000 | D | — | Jun 3, 2025 | Common Stock | 5,000 | 132,235 | D |
Explanation of responses
- F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F225% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019.